Is it the Right Time to Hold EW Stock in Your Portfolio Now? [Yahoo! Finance]
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Yahoo! Finance
Edwards Lifesciences ' EW strategic decision to divest its Critical Care segment aligns with its vision to create a comprehensive portfolio for structural heart disease. Innovations such as the RESILLIA technology enhance the performance of the company's TAVR (Transcatheter Aortic Valve Replacement) business. Additionally, progress within the TMTT (Transcatheter Mitral and Tricuspid Therapies) portfolio instils optimism. However, adverse macroeconomic impacts and currency fluctuations raise concerns for Edwards' operations. In the past year, this Zacks Rank #3 (Hold) stock has dropped 8.6% against the 22.4% rise of the industry and the S&P 500 composite's gain of 33.8%. The renowned global medical device company has a market capitalization of $39.22 billion. EW's earnings surpassed estimates in one of the trailing four quarters and matched on three occasions, the average surprise of 0.8%. Factors Driving EW Stock Critical Care Divestment — A Strategic Move: On June 3, 2024,
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Levi & Korsinsky Investigates Possible Securities Fraud Violations by Edwards Lifesciences Corporation (EW)Accesswire
- Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Citigroup Inc. from $83.00 to $77.00. They now have a "buy" rating on the stock.MarketBeat
- Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Evercore ISI from $76.00 to $70.00. They now have an "in-line" rating on the stock.MarketBeat
- Edwards Lifesciences Corporation (NYSE:EW) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? [Yahoo! Finance]Yahoo! Finance
- EW ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Edwards Lifesciences CorporationAccesswire
EW
Earnings
- 7/24/24 - In-Line
EW
Sec Filings
- 10/4/24 - Form SC
- 9/16/24 - Form 4
- 9/16/24 - Form 4
- EW's page on the SEC website